Provided by Tiger Fintech (Singapore) Pte. Ltd.

TriSalus Life Sciences Inc.

5.00
+0.10002.04%
Volume:21.34K
Turnover:105.44K
Market Cap:189.19M
PE:-4.39
High:5.06
Open:4.90
Low:4.85
Close:4.90
Loading ...

Lake Street Keeps Their Buy Rating on TriSalus Life Sciences (TLSI)

TIPRANKS
·
24 Jun

TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series a Convertible Preferred Stock to Streamline Capital Structure

THOMSON REUTERS
·
24 Jun

TriSalus Life Sciences Announces Plan to Convert Preferred Shares to Common Stock, Streamlining Capital Structure

Reuters
·
24 Jun

TriSalus Life Sciences Inc. Conducted Annual Shareholder Meeting

Reuters
·
17 Jun

TriSalus Life Sciences (TLSI) Receives a Buy from Cantor Fitzgerald

TIPRANKS
·
09 Jun

TriSalus Life Sciences Unveils TriNav FLX Infusion System with Enhanced Trackability and Precision for Solid Tumor Treatment

Reuters
·
04 Jun

TriSalus Life Sciences (TLSI) Gets a Buy from Cantor Fitzgerald

TIPRANKS
·
02 Jun

TriSalus Life Sciences files to sell 5.5M shares of common stock for holders

TIPRANKS
·
31 May

TriSalus Life Sciences Files Prospectus Relates to Offer, Sale, From Time to Time by Selling of up to 5.5 Mln Shares of Common Stock

THOMSON REUTERS
·
31 May

TriSalus Life Sciences Inc. Files Amendment to 10-K Annual Report

Reuters
·
31 May

TriSalus Life Sciences Appoints David B. Patience as New CFO Amid Leadership Transition

Reuters
·
30 May

TriSalus Life Sciences Inc - James E. Young Steps Down as CFO Effective May 30, 2025

THOMSON REUTERS
·
30 May

TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience

THOMSON REUTERS
·
30 May

Chief Regulatory Officer Jennifer Stevens Reports Disposal of Trisalus Life Sciences Inc. Common Shares

Reuters
·
22 May

Roth MKM Reaffirms Their Buy Rating on TriSalus Life Sciences (TLSI)

TIPRANKS
·
21 May

TriSalus Life Sciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

BRIEF-Trisalus Life Sciences Q1 Pretax Profit USD -10.37 Million

Reuters
·
15 May

TriSalus Life Sciences Q1 EPS $(0.39) Misses $(0.23) Estimate, Sales $9.17M Beat $9.04M Estimate

Benzinga
·
15 May

TriSalus Life Sciences Reports 42% Revenue Growth in Q1 2025, Reduces Operating Losses to $7.3 Million

Reuters
·
15 May

TriSalus Life Sciences Inc - Not Expected to Be Ebitda Positive in 2025

THOMSON REUTERS
·
15 May